442 related articles for article (PubMed ID: 27155173)
1. Access to essential medicines to treat chronic respiratory disease in low-income countries.
Bissell K; Perrin C; Beran D
Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
[TBL] [Abstract][Full Text] [Related]
2. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
3. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
Babar ZU; Lessing C; Mace C; Bissell K
Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
[TBL] [Abstract][Full Text] [Related]
4. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
Mendis S; Fukino K; Cameron A; Laing R; Filipe A; Khatib O; Leowski J; Ewen M
Bull World Health Organ; 2007 Apr; 85(4):279-88. PubMed ID: 17546309
[TBL] [Abstract][Full Text] [Related]
5. Availability, price and affordability of asthma medicines in five Indian states.
Kotwani A
Int J Tuberc Lung Dis; 2009 May; 13(5):574-9. PubMed ID: 19383189
[TBL] [Abstract][Full Text] [Related]
6. Availability and affordability of antimalarial and antibiotic medicines in Malawi.
Khuluza F; Heide L
PLoS One; 2017; 12(4):e0175399. PubMed ID: 28419126
[TBL] [Abstract][Full Text] [Related]
7. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
[TBL] [Abstract][Full Text] [Related]
8. Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study.
Stolbrink M; Ozoh OB; Halpin DMG; Nightingale R; Meghji J; Plum C; Allwood BW; Jayasooriya S; Mortimer K;
Thorax; 2024 Jun; 79(7):676-679. PubMed ID: 38760170
[TBL] [Abstract][Full Text] [Related]
9. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
[TBL] [Abstract][Full Text] [Related]
10. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
11. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
Sado E; Sufa A
BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
[TBL] [Abstract][Full Text] [Related]
12. Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda: A descriptive time series analysis.
Armstrong-Hough M; Sharma S; Kishore SP; Akiteng AR; Schwartz JI
PLoS One; 2020; 15(12):e0241555. PubMed ID: 33362249
[TBL] [Abstract][Full Text] [Related]
13. Overcoming Obstacles To Enable Access To Medicines For Noncommunicable Diseases In Poor Countries.
Kishore SP; Kolappa K; Jarvis JD; Park PH; Belt R; Balasubramaniam T; Kiddell-Monroe R
Health Aff (Millwood); 2015 Sep; 34(9):1569-77. PubMed ID: 26355060
[TBL] [Abstract][Full Text] [Related]
14. Prices, availability and affordability of medicines in Rwanda.
Bizimana T; Kayumba PC; Heide L
PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
[TBL] [Abstract][Full Text] [Related]
15. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries.
Aït-Khaled N; Auregan G; Bencharif N; Camara LM; Dagli E; Djankine K; Keita B; Ky C; Mahi S; Ngoran K; Pham DL; Sow O; Yousser M; Zidouni N; Enarson DA
Int J Tuberc Lung Dis; 2000 Mar; 4(3):268-71. PubMed ID: 10751075
[TBL] [Abstract][Full Text] [Related]
16. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
[TBL] [Abstract][Full Text] [Related]
17. Mapping actions to improve access to medicines for mental disorders in low and middle income countries.
Barbui C; Dua T; Kolappa K; Saraceno B; Saxena S
Epidemiol Psychiatr Sci; 2017 Oct; 26(5):481-490. PubMed ID: 28067194
[TBL] [Abstract][Full Text] [Related]
18. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study.
Onyango MA; Vian T; Hirsch I; Salvi DD; Laing R; Rockers PC; Ashigbie PG; Wirtz VJ
PLoS One; 2018; 13(8):e0201917. PubMed ID: 30142218
[TBL] [Abstract][Full Text] [Related]
20. Access to medicines through health systems in low- and middle-income countries.
Ozawa S; Shankar R; Leopold C; Orubu S
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii1-iii3. PubMed ID: 31816069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]